Patient physical characteristics and primary care physician decision making in preconception genetic screening.

Public Health Genomics
V L BonhamC M McBride

Abstract

There has been growing emphasis on preconception care as a strategy to improve maternal and child health since the 1980s. Increasingly, development of genetic tests will require primary care providers to make decisions about preconception genetic screening. Limited research has been conducted on how primary care providers interpret patients' characteristics and use constructs, such as ethnicity and race, to decide whom to offer preconception genetic screening. This report assessed the influence of patient characteristics on decisions to offer preconception genetic screening. A web-based survey of family physicians was conducted. Physicians reviewed a clinical vignette that was accompanied by a picture of either a black or a white patient. Physicians indicated whether they would offer genetic screening, and if yes, what tests they would offer and what factors influenced their decisions. The majority (69.2%) of physicians reported that they would not offer genetic screening. Respondents who reviewed the vignette accompanied by a picture of the black patient were more likely to offer screening (35% vs. 26%, p = 0.0034) and rated race as more important to their decision to offer testing than those who viewed the picture of the whit...Continue Reading

References

Nov 1, 2001·Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology·R D Press
Mar 21, 2003·The New England Journal of Medicine·Richard S CooperRyk Ward
Mar 21, 2003·The New England Journal of Medicine·Esteban González BurchardNeil Risch
Mar 19, 2004·The Journal of Perinatal & Neonatal Nursing·Merry-K Moos
Sep 17, 2004·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Elaine A SugarmanBernice A Allitto
Oct 28, 2004·Nature Genetics·Lynn B Jorde, Stephen P Wooding
Dec 31, 2004·American Journal of Human Genetics·Hua TangNeil J Risch
Aug 25, 2005·JAMA : the Journal of the American Medical Association·Mike Bamshad
Oct 4, 2005·Obstetrics and Gynecology·UNKNOWN ACOG Committee on Genetics
Dec 2, 2005·Obstetrics and Gynecology·UNKNOWN Committee on Genetics, American College of Obstetricians and Gynecologists
May 20, 2006·Maternal and Child Health Journal·Margaret Comerford FredaMichele Curtis
Jun 15, 2006·Maternal and Child Health Journal·Hani K AtrashJennifer Howse
Jun 16, 2006·Maternal and Child Health Journal·Keith A Frey, Julia A Files
Jun 21, 2006·Maternal and Child Health Journal·Stuart K Shapira, Siobhan Dolan
Jan 2, 2007·Obstetrics and Gynecology·UNKNOWN ACOG Committee on Obstetrics
Jan 6, 2007·Journal of the American Board of Family Medicine : JABFM·Anne L DunlopKeith Frey
Sep 28, 2007·PLoS Medicine·Lundy BraunAlexandra E Shields
Nov 8, 2007·Evaluation & the Health Professions·Jonathan B VanGeestVerna L Welch
Nov 17, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Wayne W GrodyMichael S Watson
Jan 17, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Beth A PletcherMichael S Watson
Jan 17, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Susan J GrossUNKNOWN Professional Practice and Guidelines Committee
Dec 17, 2008·American Journal of Obstetrics and Gynecology·Hani AtrashUma M Reddy
Dec 17, 2008·American Journal of Obstetrics and Gynecology·Benjamin D SolomonW Gregory Feero

❮ Previous
Next ❯

Citations

Nov 1, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Jason M FranasiakRichard T Scott

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Genetics in Medicine : Official Journal of the American College of Medical Genetics
Beth A PletcherMichael S Watson
Genetics in Medicine : Official Journal of the American College of Medical Genetics
Susan J GrossProfessional Practice and Guidelines Committee
Obstetrics and Gynecology
Committee on Ethics, American College of Obstetricians and Gynecologists, Committee on Genetics, American College of Obstetricians and Gynecologists
© 2022 Meta ULC. All rights reserved